i-Ome® Discovery Protein Array
The i-Ome Discovery Protein Array uses the patented KREX® protein folding technology to enable accurate and reproducible profiling of patient samples against more than 1800 carefully selected full-length, properly folded proteins. Curated content focused on known and potential autoantigens helps facilitate biomarker discovery with significantly lower false discovery rates and smaller sample sizes than other technologies. The…

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The i-Ome® Discovery Protein Array enables you to profile patient samples against more than 1,800 correctly folded and functional human proteins in your own lab. The versatility of the i-Ome Protein Array Kit makes it ideal for a variety of research applications, including: Biomarker Discovery, Autoantibody Profiling, and Patient Stratification.
i-Ome Discovery protein array
The i-Ome® Discovery platform from Sengenics offers a high-throughput functional protein array for precise autoantibody profiling, crucial for understanding disease mechanisms and advancing personalized diagnostic and therapeutic approaches in precision medicine. Utilizing KREX® technology for structural preservation of antigens and offering dual isotype detection, i-Ome Discovery enables comprehensive immune response profiling with reduced false discovery rates and smaller sample sizes, facilitating efficient biomarker discovery and clinical application. Sengenics highlights how i-Ome Discovery facilitates the precise identification of autoantibodies for actionable insights. With its expansive array of over 1800 human proteins, the i-Ome Discovery represents a significant advancement in the field of auto-antibody profiling for understanding disease initiation and progression.
Why does protein folding matter?
In this video, Sengenics demonstrate the importance of protein folding and how immunoprofiling with Sengenics Microarrays can deliver actionable results.









